<h1>Shukra Pharmaceuticals Confirms Receipt of Differential Payments for Convertible Equity Warrants</h1>
Shukra Pharmaceuticals Ltd confirmed the receipt of differential upfront consideration from allottees related to its Convertible Equity Warrants, noting that these payments were made following a re-computation of the issue price. The Board took note of these transactions and confirmed compliance regarding the payment structure outlined in relation to the warrants allotted on January 28, 2026.
The company noted that allottees were required to provide an additional upfront amount of Rs. 0.39 per Warrant. This differential consideration aggregated to a total of Rs. 18,10,770/-. The requirement arose due to the re-computation of the warrant issue price from Rs. 34.00 to Rs. 35.56 per Warrant.
The Board confirmed that the allotment groups and individual allottees successfully paid this differential upfront consideration by July 13, 2026, within the prescribed period. The details of the payment received are as follows:
| Allottee | Category | Warrants Received | Differential Amount Paid |
|---|---|---|---|
| Anar Jayeshbhai Patel | Promoter - Individual | 5,00,000 | 1,95,000 |
| Dakshesh Rameshchandra Shah | Promoter - Individual | 5,00,000 | 1,95,000 |
| Anar Project Private Limited | Promoter Group - Bodies Corporate | 12,35,000 | 4,81,650 |
| Parshva Texchem India Private Limited | Promoter Group - Bodies Corporate | 12,35,000 | 4,81,650 |
| Navkar Surgical Gujarat Limited | Promoter Group - Bodies Corporate | 11,73,000 | 4,57,470 |
| Total | 464,300 | 18,10,770/ |
The company further confirmed that the balance 75% of the Warrant Issue Price remains payable by warrant holders at the time of exercising or converting the warrants into Equity Shares. Subsequently, two allottees paid the remaining differential amount corresponding to the 75% balance, totaling Rs. 20,29,950/-.
The details concerning this subsequent payment are provided below:
| Allottee | Category | Warrants Received | Balance Amount Paid |
|---|---|---|---|
| Dakshesh Rameshchandra Shah | Promoter - Individual | 5,00,000 | 5,85,000 |
| Parshva Texchem India Private Limited | Promoter Group - Bodies Corporate | 12,35,000 | 14,44,950 |
| Total | 173,500 | 20,29,950/ |
The company has therefore confirmed the receipt of the necessary Differential Amount from all concerned parties.
Stock Price Movement
Shukra Pharmaceuticals Ltd settled on Tuesday at ₹34.73, gaining 2.48% in market trading. The shares experienced volatility during the session, moving between an intraday low of ₹33.29 and a high of ₹34.95.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.